 | • レポートコード：QFJ1-4440 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、長寿＆老化防止治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療）、用途別市場規模（病院、医療機関、医薬品・機器販売）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・長寿＆老化防止治療の市場動向 ・企業の競争状況、市場シェア ・長寿＆老化防止治療の種類別市場規模と予測2016-2027（溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療） ・長寿＆老化防止治療の用途別市場規模と予測2016-2027（病院、医療機関、医薬品・機器販売） ・長寿＆老化防止治療の北米市場規模2016-2027（アメリカ、カナダ） ・長寿＆老化防止治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・長寿＆老化防止治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・長寿＆老化防止治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・長寿＆老化防止治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CohBar、TA Sciences、Unity Biotechnology、AgeX Therapeutics，Inc、PowerVision Inc.） ・結論 |
Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.
Market Analysis and Insights: Global Longevity and Anti-senescence Therapy Market
The global Longevity and Anti-senescence Therapy market size is projected to reach US$ 566.4 million by 2027, from US$ 318.4 million in 2020, at a CAGR of 8.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Longevity and Anti-senescence Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Longevity and Anti-senescence Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Longevity and Anti-senescence Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Longevity and Anti-senescence Therapy market.
Global Longevity and Anti-senescence Therapy Scope and Market Size
Longevity and Anti-senescence Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Longevity and Anti-senescence Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hemolytic Drug Therapy
Gene Therapy
Immunotherapy
Other Stem Cell Therapies
Segment by Application
Hospital
Medical Service Institution
Drug and Device Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
CohBar
TA Sciences
Unity Biotechnology
AgeX Therapeutics，Inc
PowerVision Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hemolytic Drug Therapy
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Other Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Longevity and Anti-senescence Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Service Institution
1.3.4 Drug and Device Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Longevity and Anti-senescence Therapy Market Perspective (2016-2027)
2.2 Longevity and Anti-senescence Therapy Growth Trends by Regions
2.2.1 Longevity and Anti-senescence Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Longevity and Anti-senescence Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Longevity and Anti-senescence Therapy Industry Dynamic
2.3.1 Longevity and Anti-senescence Therapy Market Trends
2.3.2 Longevity and Anti-senescence Therapy Market Drivers
2.3.3 Longevity and Anti-senescence Therapy Market Challenges
2.3.4 Longevity and Anti-senescence Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue
3.1.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue (2016-2021)
3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
3.4 Global Longevity and Anti-senescence Therapy Market Concentration Ratio
3.4.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 2020
3.5 Longevity and Anti-senescence Therapy Key Players Head office and Area Served
3.6 Key Players Longevity and Anti-senescence Therapy Product Solution and Service
3.7 Date of Enter into Longevity and Anti-senescence Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Longevity and Anti-senescence Therapy Breakdown Data by Type
4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2016-2021)
4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2022-2027)
5 Longevity and Anti-senescence Therapy Breakdown Data by Application
5.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Application (2016-2021)
5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Longevity and Anti-senescence Therapy Market Size (2016-2027)
6.2 North America Longevity and Anti-senescence Therapy Market Size by Type
6.2.1 North America Longevity and Anti-senescence Therapy Market Size by Type (2016-2021)
6.2.2 North America Longevity and Anti-senescence Therapy Market Size by Type (2022-2027)
6.2.3 North America Longevity and Anti-senescence Therapy Market Size by Type (2016-2027)
6.3 North America Longevity and Anti-senescence Therapy Market Size by Application
6.3.1 North America Longevity and Anti-senescence Therapy Market Size by Application (2016-2021)
6.3.2 North America Longevity and Anti-senescence Therapy Market Size by Application (2022-2027)
6.3.3 North America Longevity and Anti-senescence Therapy Market Size by Application (2016-2027)
6.4 North America Longevity and Anti-senescence Therapy Market Size by Country
6.4.1 North America Longevity and Anti-senescence Therapy Market Size by Country (2016-2021)
6.4.2 North America Longevity and Anti-senescence Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Longevity and Anti-senescence Therapy Market Size (2016-2027)
7.2 Europe Longevity and Anti-senescence Therapy Market Size by Type
7.2.1 Europe Longevity and Anti-senescence Therapy Market Size by Type (2016-2021)
7.2.2 Europe Longevity and Anti-senescence Therapy Market Size by Type (2022-2027)
7.2.3 Europe Longevity and Anti-senescence Therapy Market Size by Type (2016-2027)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Application
7.3.1 Europe Longevity and Anti-senescence Therapy Market Size by Application (2016-2021)
7.3.2 Europe Longevity and Anti-senescence Therapy Market Size by Application (2022-2027)
7.3.3 Europe Longevity and Anti-senescence Therapy Market Size by Application (2016-2027)
7.4 Europe Longevity and Anti-senescence Therapy Market Size by Country
7.4.1 Europe Longevity and Anti-senescence Therapy Market Size by Country (2016-2021)
7.4.2 Europe Longevity and Anti-senescence Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Longevity and Anti-senescence Therapy Market Size (2016-2027)
8.2 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type
8.2.1 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application
8.3.1 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region
8.4.1 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Longevity and Anti-senescence Therapy Market Size (2016-2027)
9.2 Latin America Longevity and Anti-senescence Therapy Market Size by Type
9.2.1 Latin America Longevity and Anti-senescence Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Longevity and Anti-senescence Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Longevity and Anti-senescence Therapy Market Size by Type (2016-2027)
9.3 Latin America Longevity and Anti-senescence Therapy Market Size by Application
9.3.1 Latin America Longevity and Anti-senescence Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Longevity and Anti-senescence Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Longevity and Anti-senescence Therapy Market Size by Application (2016-2027)
9.4 Latin America Longevity and Anti-senescence Therapy Market Size by Country
9.4.1 Latin America Longevity and Anti-senescence Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Longevity and Anti-senescence Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Longevity and Anti-senescence Therapy Market Size (2016-2027)
10.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type
10.2.1 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application
10.3.1 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country
10.4.1 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CohBar
11.1.1 CohBar Company Details
11.1.2 CohBar Business Overview
11.1.3 CohBar Longevity and Anti-senescence Therapy Introduction
11.1.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2016-2021)
11.1.5 CohBar Recent Development
11.2 TA Sciences
11.2.1 TA Sciences Company Details
11.2.2 TA Sciences Business Overview
11.2.3 TA Sciences Longevity and Anti-senescence Therapy Introduction
11.2.4 TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2016-2021)
11.2.5 TA Sciences Recent Development
11.3 Unity Biotechnology
11.3.1 Unity Biotechnology Company Details
11.3.2 Unity Biotechnology Business Overview
11.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction
11.3.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2016-2021)
11.3.5 Unity Biotechnology Recent Development
11.4 AgeX Therapeutics，Inc
11.4.1 AgeX Therapeutics，Inc Company Details
11.4.2 AgeX Therapeutics，Inc Business Overview
11.4.3 AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Introduction
11.4.4 AgeX Therapeutics，Inc Revenue in Longevity and Anti-senescence Therapy Business (2016-2021)
11.4.5 AgeX Therapeutics，Inc Recent Development
11.5 PowerVision Inc.
11.5.1 PowerVision Inc. Company Details
11.5.2 PowerVision Inc. Business Overview
11.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Introduction
11.5.4 PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2016-2021)
11.5.5 PowerVision Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hemolytic Drug Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Other Stem Cell Therapies
Table 6. Global Longevity and Anti-senescence Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Longevity and Anti-senescence Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Longevity and Anti-senescence Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Longevity and Anti-senescence Therapy Market Share by Regions (2016-2021)
Table 10. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Longevity and Anti-senescence Therapy Market Share by Regions (2022-2027)
Table 12. Longevity and Anti-senescence Therapy Market Trends
Table 13. Longevity and Anti-senescence Therapy Market Drivers
Table 14. Longevity and Anti-senescence Therapy Market Challenges
Table 15. Longevity and Anti-senescence Therapy Market Restraints
Table 16. Global Longevity and Anti-senescence Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Longevity and Anti-senescence Therapy Market Share by Players (2016-2021)
Table 18. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2020)
Table 19. Ranking of Global Top Longevity and Anti-senescence Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Longevity and Anti-senescence Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Longevity and Anti-senescence Therapy Product Solution and Service
Table 23. Date of Enter into Longevity and Anti-senescence Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Longevity and Anti-senescence Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Longevity and Anti-senescence Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Longevity and Anti-senescence Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Longevity and Anti-senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Longevity and Anti-senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Longevity and Anti-senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Longevity and Anti-senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Longevity and Anti-senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Longevity and Anti-senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Longevity and Anti-senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Longevity and Anti-senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Longevity and Anti-senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Longevity and Anti-senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Longevity and Anti-senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Longevity and Anti-senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Longevity and Anti-senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Longevity and Anti-senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Longevity and Anti-senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. CohBar Company Details
Table 64. CohBar Business Overview
Table 65. CohBar Longevity and Anti-senescence Therapy Product
Table 66. CohBar Revenue in Longevity and Anti-senescence Therapy Business (2016-2021) & (US$ Million)
Table 67. CohBar Recent Development
Table 68. TA Sciences Company Details
Table 69. TA Sciences Business Overview
Table 70. TA Sciences Longevity and Anti-senescence Therapy Product
Table 71. TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2016-2021) & (US$ Million)
Table 72. TA Sciences Recent Development
Table 73. Unity Biotechnology Company Details
Table 74. Unity Biotechnology Business Overview
Table 75. Unity Biotechnology Longevity and Anti-senescence Therapy Product
Table 76. Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2016-2021) & (US$ Million)
Table 77. Unity Biotechnology Recent Development
Table 78. AgeX Therapeutics，Inc Company Details
Table 79. AgeX Therapeutics，Inc Business Overview
Table 80. AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Product
Table 81. AgeX Therapeutics，Inc Revenue in Longevity and Anti-senescence Therapy Business (2016-2021) & (US$ Million)
Table 82. AgeX Therapeutics，Inc Recent Development
Table 83. PowerVision Inc. Company Details
Table 84. PowerVision Inc. Business Overview
Table 85. PowerVision Inc. Longevity and Anti-senescence Therapy Product
Table 86. PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2016-2021) & (US$ Million)
Table 87. PowerVision Inc. Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Longevity and Anti-senescence Therapy Market Share by Type: 2020 VS 2027
Figure 2. Hemolytic Drug Therapy Features
Figure 3. Gene Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Other Stem Cell Therapies Features
Figure 6. Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Medical Service Institution Case Studies
Figure 9. Drug and Device Sales Case Studies
Figure 10. Longevity and Anti-senescence Therapy Report Years Considered
Figure 11. Global Longevity and Anti-senescence Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Longevity and Anti-senescence Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Longevity and Anti-senescence Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Longevity and Anti-senescence Therapy Market Share by Regions (2022-2027)
Figure 15. Global Longevity and Anti-senescence Therapy Market Share by Players in 2020
Figure 16. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2020
Figure 18. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Longevity and Anti-senescence Therapy Market Share by Type (2016-2027)
Figure 22. North America Longevity and Anti-senescence Therapy Market Share by Application (2016-2027)
Figure 23. North America Longevity and Anti-senescence Therapy Market Share by Country (2016-2027)
Figure 24. United States Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Longevity and Anti-senescence Therapy Market Share by Type (2016-2027)
Figure 28. Europe Longevity and Anti-senescence Therapy Market Share by Application (2016-2027)
Figure 29. Europe Longevity and Anti-senescence Therapy Market Share by Country (2016-2027)
Figure 30. Germany Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Longevity and Anti-senescence Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Longevity and Anti-senescence Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Longevity and Anti-senescence Therapy Market Share by Region (2016-2027)
Figure 40. China Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Longevity and Anti-senescence Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Longevity and Anti-senescence Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Longevity and Anti-senescence Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Longevity and Anti-senescence Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Longevity and Anti-senescence Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Longevity and Anti-senescence Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Longevity and Anti-senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. CohBar Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2016-2021)
Figure 60. TA Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2016-2021)
Figure 61. Unity Biotechnology Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2016-2021)
Figure 62. AgeX Therapeutics，Inc Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2016-2021)
Figure 63. PowerVision Inc. Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…- 長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
- 長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
- 世界の抗老化療法市場規模・現状・予測（2021年-2027年） Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consum…
- 老化防止療法のグローバル市場：規模・現状・予測2019-2025 Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consum…